Novel Mechanisms Modulating Palmitate-Induced Inflammatory Factors in Hypertrophied 3T3-L1 Adipocytes by AMPK
Objective. A growing body of evidence indicates that AMP-activated protein kinase (AMPK) contributes to not only energy metabolic homeostasis but also the inhibition of inflammatory responses. However, the underlying mechanisms remain unclear. To elucidate the role of AMPK, in this study, we observe...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2018/9256482 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832558096371679232 |
---|---|
author | Naru Morita Toshio Hosaka Atsuko Kitahara Toshitaka Murashima Hirohisa Onuma Yoshikazu Sumitani Kazuto Takahashi Toshiaki Tanaka Takuma Kondo Hitoshi Ishida |
author_facet | Naru Morita Toshio Hosaka Atsuko Kitahara Toshitaka Murashima Hirohisa Onuma Yoshikazu Sumitani Kazuto Takahashi Toshiaki Tanaka Takuma Kondo Hitoshi Ishida |
author_sort | Naru Morita |
collection | DOAJ |
description | Objective. A growing body of evidence indicates that AMP-activated protein kinase (AMPK) contributes to not only energy metabolic homeostasis but also the inhibition of inflammatory responses. However, the underlying mechanisms remain unclear. To elucidate the role of AMPK, in this study, we observed the effects of AMPK activation on monocyte chemoattractant protein-1 (MCP-1) release in mature 3T3-L1 adipocytes. Methods. We observed signal transduction pathways regulating MCP-1, which increased in obese adipocytes, in an in vitro model of hypertrophied 3T3-L1 adipocytes preloaded with palmitate. Results. Palmitate-preloaded cells exhibited significant increase in MCP-1 release and triglyceride (TG) deposition. Increased MCP-1 release and TG deposition were significantly decreased by an AMPK activator. In addition, the AMPK activator not only markedly diminished MCP-1 secretion but also augmented phosphorylation of nuclear factor-κB (NF-κB) and extracellular signal-regulated kinase (ERK) 1/2. In contrast, MCP-1 release suppression was abolished by the AMPK inhibitor compound C and the MEK inhibitor U0126. Conclusions. MCP-1 release from hypertrophied adipocytes is suppressed by AMPK activation through the NF-κB and ERK pathways. These findings provide evidence that AMPK plays a crucial role in ameliorating obesity-induced inflammation. |
format | Article |
id | doaj-art-4c32905f13514fb9b63c945d784b61b8 |
institution | Kabale University |
issn | 2314-6745 2314-6753 |
language | English |
publishDate | 2018-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Diabetes Research |
spelling | doaj-art-4c32905f13514fb9b63c945d784b61b82025-02-03T01:33:12ZengWileyJournal of Diabetes Research2314-67452314-67532018-01-01201810.1155/2018/92564829256482Novel Mechanisms Modulating Palmitate-Induced Inflammatory Factors in Hypertrophied 3T3-L1 Adipocytes by AMPKNaru Morita0Toshio Hosaka1Atsuko Kitahara2Toshitaka Murashima3Hirohisa Onuma4Yoshikazu Sumitani5Kazuto Takahashi6Toshiaki Tanaka7Takuma Kondo8Hitoshi Ishida9Third Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanThird Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanThird Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanThird Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanThird Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanThird Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanThird Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanThird Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanThird Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanThird Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanObjective. A growing body of evidence indicates that AMP-activated protein kinase (AMPK) contributes to not only energy metabolic homeostasis but also the inhibition of inflammatory responses. However, the underlying mechanisms remain unclear. To elucidate the role of AMPK, in this study, we observed the effects of AMPK activation on monocyte chemoattractant protein-1 (MCP-1) release in mature 3T3-L1 adipocytes. Methods. We observed signal transduction pathways regulating MCP-1, which increased in obese adipocytes, in an in vitro model of hypertrophied 3T3-L1 adipocytes preloaded with palmitate. Results. Palmitate-preloaded cells exhibited significant increase in MCP-1 release and triglyceride (TG) deposition. Increased MCP-1 release and TG deposition were significantly decreased by an AMPK activator. In addition, the AMPK activator not only markedly diminished MCP-1 secretion but also augmented phosphorylation of nuclear factor-κB (NF-κB) and extracellular signal-regulated kinase (ERK) 1/2. In contrast, MCP-1 release suppression was abolished by the AMPK inhibitor compound C and the MEK inhibitor U0126. Conclusions. MCP-1 release from hypertrophied adipocytes is suppressed by AMPK activation through the NF-κB and ERK pathways. These findings provide evidence that AMPK plays a crucial role in ameliorating obesity-induced inflammation.http://dx.doi.org/10.1155/2018/9256482 |
spellingShingle | Naru Morita Toshio Hosaka Atsuko Kitahara Toshitaka Murashima Hirohisa Onuma Yoshikazu Sumitani Kazuto Takahashi Toshiaki Tanaka Takuma Kondo Hitoshi Ishida Novel Mechanisms Modulating Palmitate-Induced Inflammatory Factors in Hypertrophied 3T3-L1 Adipocytes by AMPK Journal of Diabetes Research |
title | Novel Mechanisms Modulating Palmitate-Induced Inflammatory Factors in Hypertrophied 3T3-L1 Adipocytes by AMPK |
title_full | Novel Mechanisms Modulating Palmitate-Induced Inflammatory Factors in Hypertrophied 3T3-L1 Adipocytes by AMPK |
title_fullStr | Novel Mechanisms Modulating Palmitate-Induced Inflammatory Factors in Hypertrophied 3T3-L1 Adipocytes by AMPK |
title_full_unstemmed | Novel Mechanisms Modulating Palmitate-Induced Inflammatory Factors in Hypertrophied 3T3-L1 Adipocytes by AMPK |
title_short | Novel Mechanisms Modulating Palmitate-Induced Inflammatory Factors in Hypertrophied 3T3-L1 Adipocytes by AMPK |
title_sort | novel mechanisms modulating palmitate induced inflammatory factors in hypertrophied 3t3 l1 adipocytes by ampk |
url | http://dx.doi.org/10.1155/2018/9256482 |
work_keys_str_mv | AT narumorita novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk AT toshiohosaka novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk AT atsukokitahara novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk AT toshitakamurashima novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk AT hirohisaonuma novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk AT yoshikazusumitani novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk AT kazutotakahashi novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk AT toshiakitanaka novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk AT takumakondo novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk AT hitoshiishida novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk |